Featured Research

from universities, journals, and other organizations

UCLA Brain Researchers Uncover New Clues To SIDS

Date:
November 23, 2004
Source:
University Of California - Los Angeles
Summary:
Two new UCLA studies have identified brain irregularities in children who suffer from congenital central hypoventilation syndrome (CCHS), a disease in which children stop breathing during sleep, often resulting in their suffocation and death.

Two new UCLA studies have identified brain irregularities in children who suffer from congenital central hypoventilation syndrome (CCHS), a disease in which children stop breathing during sleep, often resulting in their suffocation and death. The scientists tested how CCHS children's brains react to carbon dioxide and low oxygen levels in comparison to the brains of healthy children.

Several unexpected regions in the healthy children's brains responded to the gases – particularly in sites that perceive and react to the sensation of breathlessness during suffocation. The same regions in CCHS children's brains responded poorly or not at all. This may explain why the children do not struggle to breathe when their lungs shut down -- even after turning blue from lack of air.

The findings suggest that the irregular brain mechanisms provoking CCHS may also underlie sudden infant death syndrome (SIDS). Children afflicted by the two conditions share many of the same symptoms and health problems.

Authors of the study are Ronald Harper, Ph.D., professor of neurobiology, and Paul Macey, Ph.D., neurobiology postdoctoral researcher, at the David Geffen School of Medicine at UCLA.

Their findings appear in Journal of Neurophysiology, Nov. 3, 2004, "Hypoventilation reveals central nervous system respiratory control mechanisms" http://jn.physiology.org/papbyrecent.shtmlJournal of Applied Physiology, Nov. 5, 2004, "Hypoxia reveals posterior thalamic, cerebellar, midbrain and limbic deficits in congenital central hypoventilation syndrome" http://jap.physiology.org/papbyrecent.shtml


Story Source:

The above story is based on materials provided by University Of California - Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - Los Angeles. "UCLA Brain Researchers Uncover New Clues To SIDS." ScienceDaily. ScienceDaily, 23 November 2004. <www.sciencedaily.com/releases/2004/11/041123102746.htm>.
University Of California - Los Angeles. (2004, November 23). UCLA Brain Researchers Uncover New Clues To SIDS. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/11/041123102746.htm
University Of California - Los Angeles. "UCLA Brain Researchers Uncover New Clues To SIDS." ScienceDaily. www.sciencedaily.com/releases/2004/11/041123102746.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins